semaglutide black box warning The U.S. health regulator asked drugmakers to remove label warnings about a potential risk of suicidal thoughts from widely used GLP-1 weight-loss drugs, including Novo Nordisk's Wegovy and Eli Lilly's Zepbound. https://cnn.it/49uSrKw Boxed Warning: What Does it

The product was not the FDA-approved Wegovy

Glutathione is an antioxidant tripeptide found in nearly all eukaryotes that results from cysteine, glycine, and glutamic acid [1]

Key practical points include: GLP-1 medications are often held for about 1-2 weeks before procedures involving anesthesia, such as egg retrieval, because they slow stomach emptying and may increase aspiration risk

More Patients, but Uptake Still Small Put this together and we can see that GLP-1 drugs are still on track to become major blockbusters

Whether taken by injection or pill, semaglutide works by: Reducing appetite and hunger signals in the brain Slowing how quickly food leaves the stomach Increasing feelings of fullness after meals Helping regulate blood sugar levels These effects help you eat less without feeling as hungry